Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trastuzumab in Treating Patients With Recurrent Osteosarcoma

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: April 6, 2000
Last updated: June 20, 2013
Last verified: August 2004
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2004
  Estimated Primary Completion Date: No date given